Drug Type Small molecule drug |
Synonyms XP-102SC |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
BRAF V600 mutation-positive Neoplasms | IND Approval | CN | 21 Mar 2024 |